How the Body Handles Tirzepatide: A Detailed [14C] Tracer Study in Healthy Men
Study of Tirzepatide in Healthy Participants
Study Design
Population
Healthy men (n not specified).
Intervention
A single 10 mg subcutaneous dose of [14C]tirzepatide.
Outcome
Absorption, metabolism, and excretion of tirzepatide.
Abstract
Disposition of [14C]-Tirzepatide Following Subcutaneous Administration in Healthy Male Subjects
NCT ID: NCT04311424
Status: COMPLETED
Sponsor: Eli Lilly and Company
Phase: PHASE1
Start: 2020-07-28 | Completion: 2020-10-02
Enrollment: 6 (AC…